Arxx Therapeutics

www.arxxtx.com

Founded in 2018, Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis

Read more

Reach decision makers at Arxx Therapeutics

Lusha Magic

Free credit every month!

Founded in 2018, Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis

Read more
icon

Country

icon

City (Headquarters)

Oslo

icon

Employees

11-50

icon

Founded

2018

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Vice President Clinical Research

    Email ****** @****.com
    Phone (***) ****-****
  • Board Member

    Email ****** @****.com
    Phone (***) ****-****
  • Board Member

    Email ****** @****.com
    Phone (***) ****-****
  • Chairman of the Board

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(5)

Reach decision makers at Arxx Therapeutics

Free credits every month!

My account

Sign up now to uncover all the contact details